Literature DB >> 10674665

Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia.

M Fakeeh1, A M Zaki.   

Abstract

The presence of antibodies to hepatitis C virus (HCV) was examined using a third-generation ELISA in 3,350 serum samples obtained from patients visiting different outpatient clinics, preoperative patients, and women visiting for ante-natal care at the Dr. Fakeeh hospital in Jeddah, Saudi Arabia from January to September 1998. The population included mainly Saudis, Egyptians, and Yemenis, and patients from other Middle East and Asian countries. The prevalence of HCV infection was 5.87% among Saudis, 22.54% among Egyptians, and 2.12% among Yemenis. The prevalence among patients from other Middle East and Asian countries were 3.38% and 4.98%, respectively. The overall prevalence among the studied group was 6.75%. Genotyping of isolates from Saudi Arabia showed that the prevalences of types 4, la, 1b, and 2 were 45.9%, 40.6%, 10.85%, and 2.7%, respectively. Genotyping of isolates from Egypt showed that type 4 was the major type among Egyptians (91.6%), while types 1a and 1b each had prevalences of 4.2%.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10674665     DOI: 10.4269/ajtmh.1999.61.889

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

1.  Hepatocellular carcinoma in Asia: Prevention strategy and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Afsaneh Sharifian; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-06-28

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Distribution of hepatitis C virus (HCV) genotypes in a Saudi Arabian hospital during the 2015-2020 period.

Authors:  Fadel Ali M Almosa; Ali Hassan A Alnasser; Jaffar A Al-Tawfiq
Journal:  Infez Med       Date:  2021-09-10

4.  Prevalence of antibodies to hepatitis C virus in apparently healthy Port Harcourt blood donors and association with blood groups and other risk indicators.

Authors:  Zaccheaus Awortu Jeremiah; Baribefe Koate; Fiekumo Buseri; Felix Emelike
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

5.  The prevalence of HCV antibodies in skin disease patients in Saudi Arabia.

Authors:  Mona Halawani; Amal Balbisi; Hend Alotaibi; Fahed Alsaif; Talal M Bakir
Journal:  Saudi Pharm J       Date:  2009-12-24       Impact factor: 4.330

Review 6.  Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in the management of chronic hepatitis C.

Authors:  Gillian M Keating; Monique P Curran
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  SASLT practice guidelines: management of hepatitis C virus infection.

Authors:  Abdullah S Alghamdi; Faisal M Sanai; Mona Ismail; Hamdan Alghamdi; Khalid Alswat; Adel Alqutub; Ibrahim Altraif; Hemant Shah; Faleh Z Alfaleh
Journal:  Saudi J Gastroenterol       Date:  2012-09       Impact factor: 2.485

8.  Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.

Authors:  Hamad Al Ashgar; Ahmed Helmy; Mohamed Q Khan; Khalid Al Kahtani; Mohammed Al Quaiz; Mohammed Rezeig; Ingvar Kagevi; Abdullah Alshehri; Abdullah Al Kalbani; Khalid Al Swat; Salim Dahab; Naser Elkum; Mohammed Al Fadda
Journal:  Ann Saudi Med       Date:  2009 Jan-Feb       Impact factor: 1.526

Review 9.  Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

Authors:  Ayman A Abdo; Faisal M Sanai; Faleh Z Al-Faleh
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

10.  Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.

Authors:  Hamad I Al Ashgar; Mohammed Q Khan; Mohammed Al-Ahdal; Sahar Al Thawadi; Ahmad Salem Helmy; Ahmed Al Qahtani; Faisal M Sanai
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.